Figures & data
Figure 1 Slit lamp photo showing conjunctival injection suggestive of ocular surface inflammation during a dry eye flare.
Figure 2 Schematic diagram showing the difference between conventional micro and nanoparticles gaining access to surface epithelial cells as compared with mucus penetrating particle technology. Mucus penetrating particles are engineered to effectively penetrate mucus and prevent entrapment of drug particles by mucins. Reproduced with permission from Mary Ann Liebert, Inc. publishers. Popov A. Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and nanosuspensions. J Ocul Pharmacol Ther. 2020;36(6):366–375.Citation24
